Ildiko Lingvay

  • 2830 Citations
  • 19 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ildiko Lingvay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Metformin Medicine & Life Sciences
Medical problems Chemical Compounds
pioglitazone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Placebos Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 2830 Citations
  • 19 h-Index
  • 61 Article
  • 5 Review article
  • 1 Comment/debate
Open Access
Patient Safety
Type 2 Diabetes Mellitus
Insulin
Hypoglycemia
Therapeutics

Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study

Vora, A., de Lemos, J. A., Ayers, C., Grodin, J. L. & Lingvay, I., Oct 1 2019, In : The Journal of clinical endocrinology and metabolism. 104, 10, p. 4449-4458 10 p.

Research output: Contribution to journalArticle

Galectin 3
Medical problems
Diabetes Mellitus
Biomarkers
C-Peptide

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

Leiter, L. A., Bain, S. C., Hramiak, I., Jódar, E., Madsbad, S., Gondolf, T., Hansen, T., Holst, I. & Lingvay, I., Jun 6 2019, In : Cardiovascular Diabetology. 18, 1, 73.

Research output: Contribution to journalArticle

Open Access
Risk Reduction Behavior
Type 2 Diabetes Mellitus
Stroke
Myocardial Infarction
Placebos
8 Citations (Scopus)

Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials

Aroda, V. R., Ahmann, A., Cariou, B., Chow, F., Davies, M. J., Jódar, E., Mehta, R., Woo, V. & Lingvay, I., Jan 1 2019, In : Diabetes and Metabolism.

Research output: Contribution to journalReview article

Type 2 Diabetes Mellitus
Safety
Therapeutics
Incretins
Food

Determining insulin dose at the time of discharge in a high-risk population: Is there room for improvement?

Carruthers, D., Ismaily, M., Vanderheiden, A., Yates, M., DeGueme, A., Huet, B. A., Basani, S., Abreu, M. & Lingvay, I., Mar 1 2019, In : Endocrine Practice. 25, 3, p. 263-269 7 p.

Research output: Contribution to journalArticle

Insulin
Population
Prescriptions
Ketosis
Metformin